# AstraZeneca (AZN) P/B ratio: 5.9× today, 4-year history

URL: https://funkfolio.com/stock/AZN/pb-ratio

> AstraZeneca (AZN) P/B ratio is 5.9× today, against 5.9× at the end of fiscal 2025. Its median over 4 fiscal year-ends is 5.5×.

---

## AstraZeneca (AZN) P/B ratio

**P/B ratio today:** 5.9× as of Nov 18, 2026, 10:20 AM UTC

AstraZeneca (AZN) trades at 5.9× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 5.9×. That is 17.5% higher than the 5.0× of fiscal 2024. Figures as of 18 Nov 2026, 10:20 UTC, from Yahoo Finance.

### Key facts

- **P/B ratio today:** 5.9×
- **P/B ratio, fiscal 2025:** 5.9×
- **Change on fiscal 2024:** +17.5%
- **Highest on record:** 5.9× fiscal 2025
- **Lowest on record:** 5.0× fiscal 2024
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 10:20 UTC. Statements from Yahoo Finance. Figures, not advice.

### AstraZeneca P/B ratio, in more detail

Today's figure is 0.9% below the fiscal 2025 year-end.

Across the 4 fiscal year-ends on record (2022–2025), the highest was 5.9× in fiscal 2025 and the lowest 5.0× in fiscal 2024. Today's P/B ratio is higher than at 75% of the 4 fiscal year-ends on record; their median is 5.5×.

### P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

### AstraZeneca P/B ratio, year by year

AstraZeneca (AZN) P/B ratio by fiscal year

| Fiscal year | P/B ratio | Change | Year ended | Share price at year-end | Book value per share |
| --- | --- | --- | --- | --- | --- |
| Today | 5.9× | — | Nov 18, 2026 | $182.27 | — |
| 2025 | 5.9× | 17.5% up | Dec 31, 2025 | $183.86 | $31.16 |
| 2024 | 5.0× | 6.6% down | Dec 31, 2024 | $131.04 | $26.09 |
| 2023 | 5.4× | 5.9% down | Dec 31, 2023 | $134.70 | $25.06 |
| 2022 | 5.7× | — | Dec 31, 2022 | $135.60 | $23.74 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

### How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

### P/B ratio at health care companies of similar size

P/B ratio of AstraZeneca and comparable companies

| Company | P/B ratio |
| --- | --- |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/pb-ratio) | 6.7× |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/pb-ratio) | 3.7× |
| [Novartis NVS](https://funkfolio.com/stock/NVS/pb-ratio) | 6.5× |
| AstraZeneca AZN | 5.8× |
| [Thermo Fisher Scientific TMO](https://funkfolio.com/stock/TMO/pb-ratio) | 4.8× |
| [Amgen AMGN](https://funkfolio.com/stock/AMGN/pb-ratio) | 28.6× |

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

### AstraZeneca, figure by figure

- [AstraZeneca market cap](https://funkfolio.com/stock/AZN/market-cap)
- [AstraZeneca revenue](https://funkfolio.com/stock/AZN/revenue)
- [AstraZeneca earnings](https://funkfolio.com/stock/AZN/earnings)
- [AstraZeneca earnings per share (EPS)](https://funkfolio.com/stock/AZN/eps)
- [AstraZeneca P/E ratio](https://funkfolio.com/stock/AZN/pe-ratio)
- [AstraZeneca P/S ratio](https://funkfolio.com/stock/AZN/ps-ratio)
- [AstraZeneca free cash flow](https://funkfolio.com/stock/AZN/free-cash-flow)
- [AstraZeneca operating margin](https://funkfolio.com/stock/AZN/operating-margin)
- [AstraZeneca dividend](https://funkfolio.com/stock/AZN/dividend)
- [AstraZeneca shares outstanding](https://funkfolio.com/stock/AZN/shares-outstanding)
- [AstraZeneca total debt](https://funkfolio.com/stock/AZN/total-debt)
- [AstraZeneca cash on hand](https://funkfolio.com/stock/AZN/cash)
- [AstraZeneca total assets](https://funkfolio.com/stock/AZN/total-assets)
- [AstraZeneca return on equity (ROE)](https://funkfolio.com/stock/AZN/roe)
- [AstraZeneca return on invested capital (ROIC)](https://funkfolio.com/stock/AZN/roic)

[AstraZeneca (AZN) overview: price, valuation and scorecard](https://funkfolio.com/stock/AZN) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### AstraZeneca P/B ratio: questions and answers

**What is AstraZeneca's P/B ratio?**

AstraZeneca (AZN) trades at 5.9× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 5.9×. That is 17.5% higher than the 5.0× of fiscal 2024.

**Is AstraZeneca's P/B ratio high or low compared with its own history?**

Today's P/B ratio is higher than at 75% of the 4 fiscal year-ends on record; their median is 5.5×.

**What are the highest and lowest P/B ratio figures on record for AstraZeneca?**

Across the 4 fiscal year-ends on record (2022–2025), the highest was 5.9× in fiscal 2025 and the lowest 5.0× in fiscal 2024.

**How is AstraZeneca's P/B ratio calculated?**

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For AstraZeneca it is on record here for 4 fiscal years, 2022 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

### Learn: P/B ratio

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [Piotroski F-score: the nine tests and what they show](https://funkfolio.com/learn/stocks/piotroski-f-score)

  The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “AstraZeneca (AZN) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/AZN/pb-ratio

Underlying data: Yahoo Finance.
